Can anyone tell me how to interpret the chairman of the thoracic society of Australia and NZ joining RSH (another respiratory monitoring company in the space) as a director instead of RAP - isn’t RAP so much more advanced with respiratory monitoring?? RAP has a market cap over double RSH so I would imagine they are?
Thoughts and analysis please?
- Forums
- ASX - By Stock
- RAP
- rap chart
rap chart, page-419
-
- There are more pages in this discussion • 4,223 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online